Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia

Blood

Volumn 121, Issue 24, 2013, Pages 4902-4905

  Rossi, Davide ^a   Spina, Valeria ^a   Bomben, Riccardo ^b   Rasi, Silvia ^a   Dal Bo, Michele ^b   Bruscaggin, Alessio ^a   Rossi, Francesca Maria ^b   Monti, Sara ^a   Degan, Massimo ^b   Ciardullo, Carmela ^a   Serra, Roberto ^a   Zucchetto, Antonella ^b   Nomdedeu, Josep ^c   Bulian, Pietro ^b   Grossi, Alberto ^d   Zaja, Francesco ^e   Pozzato, Gabriele ^f   Laurenti, Luca ^g   Efremov, Dimitar G ^h   Di Raimondo, Francesco ⁱ   Marasca, Roberto ^j   Forconi, Francesco ^k,l   Del Poeta, Giovanni ^m   Gaidano, Gianluca ^a   Gattei, Valter ^b   more..

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d Hematology Department Azienda Ospedaliero Universitaria Careggi   (Italy)

^e SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^f Maggiore Hospital   (Italy)

^g CATHOLIC UNIVERSITY   (Italy)

^h INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

ⁱ UNIVERSITY OF CATANIA   (Italy)

^j UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^k UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^l UNIVERSITY OF SIENA   (Italy)

^m UNIVERSITY OF ROME TOR VERGATA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; BIRC3 PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; NOTCH1 RECEPTOR; PROTEIN; PROTEIN P53; SF3B1 PROTEIN; UNCLASSIFIED DRUG; LYMPHOCYTE ANTIGEN RECEPTOR; NOTCH1 PROTEIN, HUMAN; PHOSPHOPROTEIN; SF3B1 PROTEIN, HUMAN; SMALL NUCLEAR RIBONUCLEOPROTEIN;

ARTICLE; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; DISEASE ASSOCIATION; DISEASE COURSE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; PREVALENCE; PRIORITY JOURNAL; STEREOTYPY; TRISOMY 12; TUMOR GENE; ADULT; AGED; B LYMPHOCYTE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENETICS; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; POINT MUTATION; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; B-LYMPHOCYTE SUBSETS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PHOSPHOPROTEINS; POINT MUTATION; RECEPTOR, NOTCH1; RECEPTORS, ANTIGEN, B-CELL; RETROSPECTIVE STUDIES; RIBONUCLEOPROTEIN, U2 SMALL NUCLEAR; SURVIVAL RATE;

MLCS; MLOWN;

EID: 84881266955     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-02-486209     Document Type: Article

References (25)

1. Gaidano G, Foà R, Dalla-Favera R. Molecular pathogenesis of chronic lymphocytic leukemia. J Clin Invest. 2012;122(10):3432-3438.
2. Döhner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343(26):1910-1916. (Pubitemid 32064784)
3. Fabbri G, Rasi S, Rossi D, et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med. 2011;208(7):1389-1401.
4. Puente XS, Pinyol M, Quesada V, et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature. 2011;475(7354):101-105.
5. Rossi D, Bruscaggin A, Spina V, et al. Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood. 2011;118(26):6904-6908.
6. Wang L, Lawrence MS, Wan Y, et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med. 2011;365(26):2497-2506.
7. Rossi D, Fangazio M, Rasi S, et al. Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia. Blood. 2012;119(12):2854-2862.
8. Burger JA, Montserrat E. Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B-cell receptor signaling. Blood. 2013;121(9):1501-1509.
9. Dühren-von Minden M, Übelhart R, Schneider D, et al. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature. 2012;489(7415):309-312.
10. Agathangelidis A, Darzentas N, Hadzidimitriou A, et al. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood. 2012;119(19):4467-4475.
11. Forconi F, Potter KN, Wheatley I, et al. The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL. Blood. 2010;115(1):71-77.
12. Chu CC, Catera R, Zhang L, et al. Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin. Blood. 2010;115(19):3907-3915.
13. Athanasiadou A, Stamatopoulos K, Gaitatzi M, Stavroyianni N, Fassas A, Anagnostopoulos A. Recurrent cytogenetic findings in subsets of patients with chronic lymphocytic leukemia expressing IgG-switched stereotyped immunoglobulins. Haematologica. 2008;93(3):473-474. (Pubitemid 351398656)
14. Marincevic M, Cahill N, Gunnarsson R, et al. High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors. Haematologica. 2010;95(9):1519-1525.
15. Thorsélius M, Kröber A, Murray F, et al. Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. Blood. 2006;107(7):2889-2894.
16. Bomben R, Dal Bo M, Capello D, et al. Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study. Blood. 2007;109(7):2989-2998. (Pubitemid 46482099)
17. Rossi D, Spina V, Cerri M, et al. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clin Cancer Res. 2009;15(13):4415-4422.
18. Murray F, Darzentas N, Hadzidimitriou A, et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood. 2008;111(3):1524-1533. (Pubitemid 351213442)
19. Messmer BT, Raphael BJ, Aerni SJ, et al. Computational identification of CDR3 sequence archetypes among immunoglobulin sequences in chronic lymphocytic leukemia. Leuk Res. 2009;33(3):368-376.
20. Balatti V, Bottoni A, Palamarchuk A, et al. NOTCH1 mutations in CLL associated with trisomy 12. Blood. 2012;119(2):329-331.
21. Del Giudice I, Rossi D, Chiaretti S, et al. NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL. Haematologica. 2012;97(3):437-441.
22. Rossi D, Rasi S, Spina V, et al. Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome. Br J Haematol. 2012;158(3):426-429.
23. Villamor N, Conde L, Martínez-Trillos A, et al. NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome [published online ahead of print December 6, 2012]. Leukemia.
24. De Re V, De Vita S, Marzotto A, et al. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood. 2000;96(10):3578-3584.
25. Seifert M, Sellmann L, Bloehdorn J, et al. Cellular origin and pathophysiology of chronic lymphocytic leukemia. J Exp Med. 2012;209(12):2183- 2198.